NCT03646071View on ClinicalTrials.gov

A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1UnknownINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 31, 2023

Study Completion Date

December 31, 2023

Conditions

Locally Advanced Solid TumorsMetastatic Solid Tumors

Interventions

DRUG

RX108

RX108

Trial Locations (2)

77030

RECRUITING

University of Texas at MD Anderson Cancer Center, Houston

90048

RECRUITING

Cedars-Sinai, Los Angeles

Sponsors

Lead Sponsor

NeuPharma, Inc.

All Listed Sponsors

lead

NeuPharma, Inc.

INDUSTRY